Skip to content
‹ Back to IndustriesHealthcare

Owning the Future of Healthcare: How Health Catalyst Drives Better Population Health Through Data

Population health may seem like a marathon, but it is immensely beneficial for patient outcomes. Jonas Varnum, Vice President of Population Health Strategic Services at Health Catalyst, joined Host Hilary Kennedy to discuss how to implement population health. The goal of population health is to create a better system with less waste. Currently, there…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
Owning the Future of Healthcare: How Health Catalyst Drives Better Population Health Through Data

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI in a free MarketScale workspace. Qualifying companies also get one professional video edit a month. No credit card.

Start free

Population health may seem like a marathon, but it is immensely beneficial for patient outcomes. Jonas Varnum, Vice President of Population Health Strategic Services at Health Catalyst, joined Host Hilary Kennedy to discuss how to implement population health.

The goal of population health is to create a better system with less waste. Currently, there are one trillion dollars in suboptimal care, which could be improved by 35 to 50 percent. Varied insurance models, such as commercial, Medicare, Medicaid, and others, provide a challenge in the different revenue they generate. Varnum explained, “The only real way to successfully deliver care is to have a scalable, systematic method of how you do population health across different patient populations.”

Implementation of population health means a system must answer innumerable use cases rapidly. They need to know how impactful certain patient populations are and ensure they are benchmarked appropriately. This includes examining whether utilization rates of certain services, such as emergency services and telehealth, are appropriate. Population health includes understanding patient population equity. Are patients receiving the right care at the right place and time?

Varnum explained how data is transferred to interventions such as care management, direct patient engagement, and quality measures. Health Catalyst embeds over 250 measures directly into the EHR. Clinicians can easily access them to meet specific criteria of the measures. This decreases administrative work and burnout.

Varnum’s take? “At the end of the day, what you really need to make sure that you’re doing, is understanding that after you worked that patient population, did it create outcomes?” He added, “The reality though is that if you actually have a systematic structure, then that marathon is a lot easier.”

Visit healthcatalyst.com for case studies and more information on population health or subscribe to the Owning the Future of Healthcare podcast.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0. No credit card. Company confirmation required.

More Healthcare Insights

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage. Holland & Knight said hospitals will be eligible for NTAP reimbursement for use of Aidoc’s CARE Body CT Multi-Triage beginning Oct. 1, 2026, with supplemental payments continuing for three years.

  • 01Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage.
  • 02Holland & Knight said CMS approved an NTAP designation for Aidoc’s CARE Body CT Multi-Triage, with hospitals eligible for NTAP reimbursement beginning Oct. 1, 2026, with supplemental payments continuing for three years.

Sep 23, 2026

Blair Health raises CAD $4.24M to expand its LLM-guided specialty care workflows

Blair Health raises CAD $4.24M to expand its LLM-guided specialty care workflows

Blair Health raised CAD $4.24 million in a pre-seed round, according to Fierce Healthcare. It plans to expand protocol-driven virtual specialty care across Canada and the U.S.

  • 01Blair Health raised CAD $4.24 million in pre-seed funding.
  • 02Qualified Health positions its AI platform around safety and governance, including clinician oversight, auditability and traceability, according to Fierce Healthcare.

Sep 23, 2026

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512